Answer | |  |
Diagnosis: Stiff skin syndromeStiff skin syndrome (SSS) is a rare disorder encountered in childhood causing fixed contracture deformity of the joints. There is no underlying musculo-skeletal or visceral involvement.
[1] Esterly and McKusik described this disorder in 1971
[2] and thereafter Jablonska described a distinct subset of the disease, "congenital fascial dystrophy."
[2] Description of SSS is heterogenous and present consensus is that it is a triad of rock-hard induration of skin, hypertrichosis and restricted joint mobility.
[3] SSS manifests in early childhood or any time by 7 years of age. It involves body areas with abundant fascia, around pelvic and shoulder girdles and thoracic wall.
SSS is insidious in onset and either advances slowly or remains non-progressive. Joint contractures develop secondary to involvement of overlying fascia and skin. Some patients may develop a tiptoe gait and barrel chest deformity due to extensive fibrosis.
[1] Diagnosis is based mainly on classical clinical presentation as there is no pathognomonic histopathological feature. In the variant designated as congenital fascial dystrophy, approximately four to six-folds thickening of the involved fascia is seen. There is a dense collection of coarse and giant collagen fibrils (amianthoid/asbestoid fibers). Fascial involvement was not demonstrable in the biopsied specimen in our patient; however, there was deposition of thick collagen in the reticular dermis. This finding is similar to that of Liu et al.,
[1] in all their six reported cases.
As evidenced by histopathological and immunopathological studies, SSS is a non-inflammatory fibrotic disorder, without any vascular hyper-reactivity.
[1] Pathogenesis of SSS is not well understood. Loeys et al.
[4] have reported that SSS is caused by mutations in the sole Arg-Gly-Asp sequence-encoding domain of fibrillin-1. Microfibrill, an ordered polymer of fibrillin-1, helps in elastic fiber assembly and activation of the profibrotic cytokine transforming growth factor-β (TGF-β). Altered cell-matrix interactions in SSS result in excessive microfibrillar deposition, impaired elastogenesis, increased TGF-β concentration, and signaling in the dermis.
Various other disorders encountered in childhood may simulate SSS.
[1] These include systemic sclerosis, generalized morphea, eosinophilic fascitis, scleredema of Buschke, and nephrogenic fibrosing dermopathy. Rare inherited disorders such as mucopolysaccharidosis, lysosomal storage disease, juvenile hyaline fibromatosis and Hutchinson-Gilford progeria may present with focal or diffuse thickening of skin, subcutaneous nodules and flexion contracture of joints.
[1] Typical clinical features of the disease, initiating during early childhood as woody induration of skin around pelvic and shoulder girdles, sparing face and distal extremities and progressive stiffness of large joints without any systemic involvement are diagnostic of SSS.
Restricted mobility is the factor impairing quality of life in SSS. Long term physiotherapy helps in rehabilitation and some of the affected patients have been reported to develop skills in sports and given child-birth.
[5] Our patient was advised active and passive physiotherapy for limb joints to improve mobility. However, she was lost for further follow up. Extensive involvement of the thoracic fascia may lead to restricted costal mobility leading to respiratory insufficiency and subsequent death.
[5],[6] Pages et al.
[6] have reported a patient with SSS, who suffered from acute abdomen due to extensive necrosis of the intestinal wall and died subsequently. Such symptoms or any respiratory symptom should be given urgent consideration in these patients as overlying rigidity of the parietal wall may make it difficult to assess the extent of underlying illness.
1. | Liu T, McCalmont TH, Frieden IJ, Williams ML, Connolly MK, Gilliam AE. The stiff skin syndrome. Case series, differential diagnosis of the stiff skin phenotype and review of the literature. Arch Dermatol 2008;144:1351-9.  [PUBMED] |
2. | Jablonska S, Groniowski J, Krieg T, Nerlich A, Peltonen L, Oikaryndinen A, et al. Congenital fascial dystrophy: A noninflammatory disease of fascia: The stiff skin syndrome. Pediatr Dermatol 1984;2:87-97.  |
3. | Caspary P, Costa F, Martins Souza PR. Familial localized stiff skin syndrome. Int J Dermatol 2010;49:842-8.  |
4. | Loeys BL, Gerber EE, Riegert-Johnson D, Iqbal S, Whiteman P, McConnell V, et al. Mutations in fibrillin-1 cause congenital scleroderma: Stiff skin syndrome. Sci Transl Med 2010;2:23ra20.  [PUBMED] |
5. | Fidzianska A, Jablonska S. Congenital fascial dystrophy: Abnormal composition of the fascia. J Am Acad Dermatol 2000;43:797-802.  [PUBMED] |
6. | Pages ON, Maliszewicz P, Lefebvrel F, Poli-Merol ML, Morville P. Visceral involvement in stiff skin syndrome. Pediatr Dermatol 2010;27:327.  |